These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11366135)

  • 1. The high cost of fighting HIV.
    Body Posit; 1998 Dec; 11(12):15. PubMed ID: 11366135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparing the protease for some spoils the price for all.
    Grinberg L
    GMHC Treat Issues; 1998 Sep; 12(9):1-2. PubMed ID: 11365802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drug pricing: progress on World AIDS Day?
    James JS
    AIDS Treat News; 1998 Dec; (No 308):8. PubMed ID: 11366077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advocates call for fair drug pricing.
    Highleyman L
    BETA; 1998 Oct; ():3. PubMed ID: 11365988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drug pricing consensus letter, sign-ons requested.
    AIDS Treat News; 1998 Sep; (302):4. PubMed ID: 11365762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drug approved.
    AIDS Policy Law; 1998 Oct; 13(18):12. PubMed ID: 11365934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA approves efavirenz. Food and Drug Administration.
    Highleyman L
    BETA; 1998 Oct; ():3. PubMed ID: 11365987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to efavirenz and amprenavir.
    Gilden D
    GMHC Treat Issues; 1998 Oct; 12(10):12. PubMed ID: 11365902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soaring prices, soaring sales.
    Grinberg L
    GMHC Treat Issues; 1998 Dec; 12(12):5-7. PubMed ID: 11366020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FDA approval of the first HIV anti-retroviral from DuPont-Pharma: SUSTIVA (efavirenz). SUSTIVA should be associated with other anti-retrovirals and could be considered a new alternative first line treatment].
    Allerg Immunol (Paris); 1998 Oct; 30(8):268-70. PubMed ID: 9846197
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustiva (efavirenz) is approved.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another expensive drug for your cocktail.
    Gilden D
    GMHC Treat Issues; 1998 Sep; 12(9):3-6. PubMed ID: 11365806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Straight talk from DuPont on Sustiva.
    Carithers GB
    Posit Living; 2000 Jul; 9(6):5, 63. PubMed ID: 12492013
    [No Abstract]   [Full Text] [Related]  

  • 14. Efavirenz (Sustiva) receives FDA approval. Food and Drug Administration.
    Proj Inf Perspect; 1998 Dec; (26):11. PubMed ID: 11366487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz (SUSTIVA) approved.
    James JS
    AIDS Treat News; 1998 Oct; (No 304):1-4. PubMed ID: 11365862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves Sustiva (efavirenz) capsules, first once-daily anti-HIV drug. Food and Drug Administration.
    Res Initiat Treat Action; 1998 Oct; 4(6):13-4. PubMed ID: 11365915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thailand and the compulsory licensing of efavirenz.
    Steinbrook R
    N Engl J Med; 2007 Feb; 356(6):544-6. PubMed ID: 17287474
    [No Abstract]   [Full Text] [Related]  

  • 18. Now approved: Sustiva in combination offers patients a new first-line therapy.
    Fac Notes (New Orleans La); 1998; 10(6):10. PubMed ID: 11366140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadened access to Sustiva.
    Bornhoeft MA
    Body Posit; 1998 Jan; 11(1):13. PubMed ID: 11365007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMP 266 (Sustiva) expanded access.
    Vazquez E; Whitfield L
    Posit Aware; 1997; 8(6):12. PubMed ID: 11364850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.